3D Signatures' Disruptive Technology Moving Ahead for Prostate Cancer and Hodgkin's Lymphoma

Disclosures from Alphastox.com, March 2, 2017, issue

Transcend Capital Inc. has been paid a fee for conducting a review of the company. The writers and editors of Alphastox.com may have positions in the stocks discussed above and may trade in the stocks mentioned.